Reported Oct 31, 2018 · Terminated
Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis…
Teva Pharmaceuticals USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceuticals USA · 1090 Horsham Rd · North Wales, PA · 19454-1505
Is this the product you have?
- Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only
- Manufactured byActavis Laboratories FL, Inc., Fort Lauderdale, FL 33314
- Distributed byActavis Pharma, Inc., Parsippany, NJ 07054, NDC 62037-831-01
- Lot codes and dates
Lot # 1220211MExp 02/2019
- Amount recalled
- 53,451 bottles
This recall covers 8 products
The agency filed one notice per product. You are reading one of them; the other 7 are below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceuticals USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.